[Esophageal dysmotility detection in patients with gastroesophageal reflux-related cough and its influence on the efficacy of anti-reflux therapy].
M R Zhang,L Zhang,Alimire Aierken,Q Chen,L Yu,X H Xu,Z M Qiu
DOI: https://doi.org/10.3760/cma.j.cn112147-20230223-00086
2023-01-01
Abstract: To investigate the characteristics of esophageal dysmotility in patients with an initial diagnosis of acid/non-acid gastroesophageal reflux-related cough (GERC), and its correlation with the therapeutic response to anti-reflux treatments to search for the useful indicators to screen patients with chronic cough suitable for anti-reflux therapy. A total of 173 patients with suspicious GERC who attended the Chronic Cough Specialist Clinic of Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University between June 2020 and December 2022 were retrospectively selected for the study. The age of the patients was (45.1±14.6) years old, including 87 males and 86 females. Their demographic characteristics, clinical manifestations, and the results of high-resolution manometry (HRM) and multichannel intraluminal impedance-pH monitoring (MII-pH) were collected. Information on the etiological identification process and final diagnosis was also recorded. The recruited cases were grouped according to therapeutic outcomes and divided into cases with a favourable response to conventional anti-reflux treatment, cases with a favourable response to intensified anti-reflux treatment, and cases with no response to anti-reflux treatment. Factors influencing the efficacy of anti-reflux treatment were investigated. Differences between groups were compared using the test, Student-Newman-Keuls test, and Kruskal-Wallis () test, where applicable. Logistic regression analysis using forward stepwise regression based on maximum likelihood estimation was used to screen for influence factors. The 175 patients with suspicious GERC included 45 (26.0%) patients who responded to conventional anti-reflux treatment, 54 (31.2%) who responded to intensified anti-reflux treatment and 74 (42.8%) who did not respond to anti-reflux therapies. Esophageal dysmotility was present in 52.0% of patients (90/173), but was less common in patients who responded to conventional anti-reflux treatment (=8.09, 0.018). Although the majority of reflux episodes were non-acid (136/173, 78.6%), the proportion of acid reflux (=19.49, <0.001) and acid exposure time (11.04, 0.004) were significantly higher in patients who responded to conventional anti-reflux treatment. The patients with acid and non-acid GERC had comparable proportion of esophageal dysmotility (64.9% 48.5%, =3.11, 0.078), with a shorter break [2.4 (0.7, 5.6) cm 6.1 (1.4, 10.0) cm, -2.39, 0.017], longer upper esophageal sphincter [(4.1±0.9) cm (3.7±1.3) cm, -2.09, 0.038], higher percentage of normal esophageal contractions [60.0% (17.8%, 90.0%) 30.0% (0, 80.0%), -2.14, 0.032], and lower percentage of large break [10.0% (0, 40.0%) 50.0% (0, 100.0%), -2.92, 0.004] in the patients with non-acid GERC. The mean resting pressure of the lower esophageal sphincter was significantly lower (7.49, 0.024), while the percentage of ineffective esophageal contractions was markedly higher (8.60, 0.014) in the patients who responded to intensified anti-reflux treatment and in the patients who did not respond to the anti-reflux therapies. Multifactorial logistic regression analysis identified the percentage of ineffective contraction as an independent factor predicting the efficacy of conventional anti-reflux treatment, with a cut-off value of≤45% and a moderate predictive value (AUC=0.67, 0.004). Esophageal dysmotility is common in GERC patients with different characteristics in acid and non-acid GERC. The percentage of ineffective esophageal contraction may be a useful indicator for selecting an anti-reflux strategy and predicting treatment outcomes.